es-dpp4i-cost-discussion

name	es-dpp4i-cost-discussion
description	Discuss cost and overall acceptability of a DPP4 inhibitor with the patient when there are plans to continue the medication after hospital discharge. Trigger phrases include: "Patient wants to continue DPP4i after discharge, should we discuss cost and access?" or "Need to address affordability of sitagliptin/linagliptin before discharge."

Discuss Cost and Overall Acceptability of DPP4i After Discharge

STEP 1 — Gather Information

• Confirm the specific DPP4i prescribed (e.g., sitagliptin, linagliptin, alogliptin) and dose.
• Verify discharge plan includes continuation of the DPP4i.
• Assess patient’s insurance status (Medicare Part D, private, Medicaid, uninsured) and prior experience with medication costs.
• Ask about any financial concerns or barriers to obtaining the medication.
• Review medication list for potential interactions or duplications.

STEP 2 — Rule In / Rule Out

• Is there a plan to continue the DPP4i after discharge?
  • Yes → Proceed to discuss cost and acceptability.
  • No → No further cost discussion needed for this medication; document decision and move to discharge planning.

STEP 3 — Classify or Stratify

• Determine affordability tier:
  • Low concern – Insurance covers with minimal copay (<$25/month) or patient assistance program available.
  • Moderate concern – Copay $25–$75/month or prior authorization required.
  • High concern – No coverage, high out‑of‑pocket (>$75/month), or patient expresses inability to pay.

STEP 4 — Decide

• If low concern: Confirm plan, provide prescription, and remind patient to use pharmacy benefits.
• If moderate concern: Explore formulary alternatives, manufacturer copay cards, or patient assistance programs; involve pharmacy or social work if needed.
• If high concern: Consider switching to a lower‑cost agent (e.g., generic metformin if appropriate) or discuss with prescribing team; document shared decision‑making and provide resources for financial aid.

Clinical Guardrails / Mimics / Pitfalls

• Do not assume the patient can afford the medication without asking.
• Do not overlook the need for prior authorization, which can delay therapy.
• Avoid prescribing a DPP4i if the patient has a history of non‑adherence due to cost without addressing it.
• Do not ignore health literacy; use plain language and teach‑back to ensure understanding of cost‑saving options.

Concrete Clinical Example

A 68‑year‑old woman with type 2 diabetes is hospitalized for pneumonia and started on sitagliptin 100 mg daily. She plans to continue it after discharge. During discharge planning, the clinician asks about her insurance; she has Medicare Part D with a $40 copay. The clinician informs her about the manufacturer’s copay card that can reduce the cost to $0 for the first year and provides the enrollment website. The patient confirms she will use the card, and the prescription is sent to her pharmacy.

Source: Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2022, https://doi.org/10.1210/clinem/dgac278